Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
Clinical trial NCT05467319 · UNKNOWN
Trial details
- NCT number
- NCT05467319
- Sponsor
- Alberta Health Services, Calgary
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2023-09-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.